Covestro Valuation

Is 029178035 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 029178035 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 029178035 (CHF53.79) is trading below our estimate of fair value (CHF126.14)

Significantly Below Fair Value: 029178035 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 029178035?

Key metric: As 029178035 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 029178035. This is calculated by dividing 029178035's market cap by their current revenue.
What is 029178035's PS Ratio?
PS Ratio0.8x
Sales€14.15b
Market Cap€10.89b

Price to Sales Ratio vs Peers

How does 029178035's PS Ratio compare to its peers?

The above table shows the PS ratio for 029178035 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4x
EMSN EMS-CHEMIE HOLDING
6.9x5.0%CHF 14.7b
CLN Clariant
0.8x4.3%CHF 3.5b
GIVN Givaudan
5x5.1%CHF 35.8b
SIKA Sika
3.1x5.1%CHF 36.6b
029178035 Covestro
0.8x4.3%CHF 10.9b

Price-To-Sales vs Peers: 029178035 is good value based on its Price-To-Sales Ratio (0.8x) compared to the peer average (4x).


Price to Sales Ratio vs Industry

How does 029178035's PS Ratio compare vs other companies in the European Chemicals Industry?

27 CompaniesPrice / SalesEstimated GrowthMarket Cap
029178035 0.8xIndustry Avg. 1.0xNo. of Companies31PS01.22.43.64.86+
27 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 029178035 is good value based on its Price-To-Sales Ratio (0.8x) compared to the European Chemicals industry average (1x).


Price to Sales Ratio vs Fair Ratio

What is 029178035's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

029178035 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.8x
Fair PS Ratio0.8x

Price-To-Sales vs Fair Ratio: 029178035 is good value based on its Price-To-Sales Ratio (0.8x) compared to the estimated Fair Price-To-Sales Ratio (0.8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 029178035 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
CHF 56.76
0%
4.2%CHF 57.77CHF 49.38n/a12
Nov ’25n/a
CHF 56.51
0%
6.3%CHF 58.32CHF 47.03n/a13
Oct ’25n/a
CHF 54.06
0%
7.4%CHF 58.08CHF 46.84n/a14
Sep ’25CHF 64.40
CHF 53.74
-16.6%
7.6%CHF 58.45CHF 47.14n/a14
Aug ’25CHF 64.40
CHF 53.74
-16.6%
7.6%CHF 58.45CHF 47.14n/a14
Jul ’25CHF 64.40
CHF 52.49
-18.5%
13.5%CHF 59.64CHF 36.55n/a14
Jun ’25CHF 64.40
CHF 51.68
-19.7%
13.4%CHF 59.56CHF 37.11n/a14
May ’25CHF 64.40
CHF 52.29
-18.8%
13.3%CHF 59.95CHF 37.34n/a14
Apr ’25CHF 64.40
CHF 51.63
-19.8%
13.4%CHF 59.27CHF 36.92n/a14
Mar ’25CHF 64.40
CHF 51.00
-20.8%
13.3%CHF 58.38CHF 36.37n/a14
Feb ’25CHF 64.40
CHF 49.52
-23.1%
13.2%CHF 57.21CHF 35.64n/a15
Jan ’25CHF 64.40
CHF 51.92
-19.4%
13.6%CHF 63.77CHF 36.72n/a15
Dec ’24CHF 64.40
CHF 51.92
-19.4%
13.6%CHF 63.77CHF 36.72n/a15
Nov ’24CHF 64.40
CHF 51.38
-20.2%
13.4%CHF 62.88CHF 36.20n/a15
Oct ’24CHF 64.40
CHF 52.38
-18.7%
13.7%CHF 63.86CHF 36.77n/a15
Sep ’24CHF 64.40
CHF 49.92
-22.5%
14.5%CHF 62.94CHF 36.24CHF 64.4017
Aug ’24CHF 64.40
CHF 47.33
-26.5%
15.6%CHF 63.45CHF 36.53CHF 64.4017
Jul ’24CHF 64.40
CHF 47.12
-26.8%
15.5%CHF 64.45CHF 37.11CHF 64.4018
Jun ’24CHF 64.40
CHF 44.85
-30.4%
14.7%CHF 63.12CHF 33.02CHF 64.4019
May ’24CHF 64.40
CHF 44.66
-30.7%
15.5%CHF 64.02CHF 33.49CHF 64.4019
Apr ’24CHF 64.40
CHF 44.15
-31.4%
17.4%CHF 63.80CHF 32.90CHF 64.4019
Mar ’24CHF 64.40
CHF 42.26
-34.4%
15.7%CHF 59.26CHF 32.59CHF 64.4019
Feb ’24CHF 64.40
CHF 42.34
-34.3%
14.6%CHF 55.96CHF 32.98CHF 64.4019
Jan ’24CHF 64.40
CHF 40.90
-36.5%
15.0%CHF 55.16CHF 30.53CHF 64.4019
Dec ’23CHF 64.40
CHF 40.61
-36.9%
15.0%CHF 55.11CHF 30.51CHF 64.4019
Nov ’23CHF 64.40
CHF 41.45
-35.6%
14.9%CHF 56.54CHF 30.75CHF 64.4019

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies